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Prader-Willi Syndrome (PWS) is a neurogenetic disorder caused by the deletion of imprinted genes on the
paternally inherited human chromosome 15q11-q13. This locus harbours a long non-protein-coding RNA
(U-UBE3A-ATS) that contains six intron-encoded snoRNAs, including the SNORD116 and SNORD115
repetitive clusters. The 39-region of U-UBE3A-ATS is transcribed in the cis-antisense direction to the
ubiquitin-protein ligase E3A (UBE3A) gene. Deletion of the SNORD116 region causes key characteristics of
PWS. There are few indications that SNORD115 might regulate serotonin receptor (5HT2C) pre-mRNA
processing. Here we performed quantitative real-time expression analyses of RNAs from the PWS locus
across 20 human tissues and combined it with deep-sequencing data derived from Cap Analysis of Gene
Expression (CAGE-seq) libraries. We found that the expression profiles of SNORD64, SNORD107,
SNORD108 and SNORD116 are similar across analyzed tissues and correlate well with SNORD116
embeddedU-UBE3A-ATS exons (IPW116). Notable differences in expressions between the aforementioned
RNAs and SNORD115 together with the host IPW115 and UBE3A cis-antisense exons were observed.
CAGE-seq analysis revealed the presence of potential transcriptional start sites originated from the U-
UBE3A-ATS spanning region. Our findings indicate novel aspects for the expression regulation in the PWS
locus.
T
he Prader-Willi (PWS) and Angelman syndromes (AS) are neurogenetic disorders that are caused by
inactivation or inherited deletion of paternally and maternally expressed genes on human chromosome
15q11-q13, respectively. AS is characterized by cognitive impairment, absence of speech, seizures, ataxia and
mental retardation. Genetically, AS is linked to deletion or inactivating mutations of the ubiquitin E3 ligase
encoding gene (UBE3A) on humanmaternally inherited chromosome 15 (Figure 1). Individuals with PWS suffer
initially from hypotonia, neonatal feeding difficulties and failure to thrive. The PWS symptoms of later stages
include hyperphagia, which if not controlled leads to obesity, general and continued development delay, small
hands and feet, behavioral problems and mild intellectual disability1. PWS disorder results from the loss of
function of one or more imprinted, paternally expressed genes on the proximal long arm of chromosome 15
(Figure 1)2,3. The PWS locus consists of several paternally expressed protein-coding genes, a piRNA gene cluster
and six different C/D-box snoRNA species4,5. Two of them: SNORD116 (HBII-85) and SNORD115 (HBII-52) are
organized in large, tandemly repeated clusters, containing 29 and 48 gene copies respectively (Figure 1). Other
snoRNAs are present either as single copy (SNORD64 (HBII-13), SNORD107 (HBII-436) and SNORD108
(HBII-437)) or double copy (SNORD109A/B (HBII-438A/B)) genes3,4,6. The piRNA cluster is located within
the humanX15ORF2/NPAP1 gene, suggesting that it can be recognized and silenced as an invasive gene by RNA-
mediated mechanisms7. Several studies indicate that all snoRNAs are likely to be processed from the introns of a
long primary non-protein coding transcript (U-UBE3A-ATS) (Figure 1)3. This large .600 kb long transcript,
which reportedly initiates from U-exons upstream from SNURF/SNRPN encoding gene, includes the PWS-
imprinting center (PWS-IC) and extends to overlap in antisense orientation with the UBE3A gene region
(Figure 1)3,8–10. However, some observations point to the possible presence of additional regulatory elements
or differential processing of the distal region of the U-UBE3A-ATS transcript (UBE3A-ATS)11. There are reports
indicating that SNORD64, SNORD107, SNORD108, SNORD109A, SNORD116 and their hosting exons of U-
UBE3A-ATS RNA (including IPW116 exons: previously known as IPW-A1 and IPW-A2) are ubiquitously
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by IPW115 exons (previously known as IPW-G1 and IPW-G2) and
the SNORD109B together with the distal part of UBE3A antisense
region (UBE3A-ATS) is restricted to neurons (Figure 1)12,13.
However, there are also studies identifying SNORD115 in a few other
human tissues4,14.
Based on mouse models, two groups reported that deletion of the
SNORD116 genes cluster together with IPW116 exons results in
postnatal growth retardation15,16. Subsequently, patients with similar
micro-deletions of the SNORD116 genomic region that exhibited
key characteristics of Prader-Willi syndrome were described17. Never-
theless, the question of the functional significance of SNORD116 in
PWS is still unknown. The contribution of the IPW116 exons as part
of the U-UBE3A-ATS long non-protein coding RNA in PWS should
also be considered11,15,18. Moreover, chimeric long non-protein coding
RNA containing the IPW116 exon flanked by two SNORD116 RNAs
(previously known as PWCR119; GenBank: AF241255.1) was shown
to sequester the Fox2 splicing factor resulting in alteration of pre-
mRNAs splicing pattern20. In addition, the cumulative impact to the
full-fledged PWS phenotype of different genes located in the PWS
region is a viable possibility21–23.
Although the involvement of SNORD115 in PWS syndrome is
questionable, as loss of the snoRNA cluster does not lead to PWS
phenotype17,24, an antisense element within SNORD115 is comple-
mentary to an alternatively spliced exon of the 5HT-2C serotonin
receptor pre-mRNA. The snoRNA target region is located within a
sequence that is subject to post-transcriptional editing4. Subse-
quently, it was shown that the SNORD115 guide element might
regulate A to I editing. However, this occurs only if the target RNA
is transcribed in the nucleolus under control of RNA polymerase I
promoter25. In vitro experiments show that SNORD115 could inter-
fere with alternative splicing of the 5HT-2C serotonin receptor pre-
mRNA. However, in these experiments the corresponding splice site
of the pre-mRNA was mutated26. In addition, the transcription of
long cis-antisense non-protein coding UBE3A-ATS RNA (that is
predicted to include part of IPW115 exons) on the paternal chro-
mosome has been reported to negatively regulate UBE3A expression
in neurons, thereby determining the tissue-specific imprinting of the
UBE3A gene in human and mouse brain12,13,27,28.
We have performed a novel comprehensive analysis of the express-
ion profile of long and small non-protein coding RNAs from PWS
locus in 20 different human tissues. In addition, an expression profile
of the Angelman syndrome gene (UBE3A) across investigated tissues
was also determined. Obtained data demonstrate that SNORD64,
SNORD107, SNORD108, SNORD116 snoRNAs and IPW116 exons
exhibit expression patterns different from SNORD115 and IPW115
exons. Expression profiles of investigated UBE3A cis-antisense exons
of UBE3A-ATS transcript did not correlate with snoRNAs or with
IPW116 and IPW115 exons of long non-protein coding RNAs
(npcRNAs). The UBE3A expression revealed minimal deviation
across tissues. We also performed analysis of RNA-seq reads derived
from Cap Analysis of Gene Expression (CAGE-seq) libraries of
human cell lines and tissues. The transcripts potentially initiated
within and between snoRNA clusters were identified. Our findings
provide evidence for widespread expression of the investigated non-
protein coding RNAs from the PWS locus and point to additional
aspects in regulation of SNORD115 and the distal region of the
UBE3A-ATS transcript in human.
Results
Assembling a npcRNA ‘Expression Ruler’. Quantitative real-time
PCR (qPCR) gene expression analysis is a powerful tool that requires
minimal sample material, time and efforts. However, considering the
technical and experimental variation in starting materials due to e.g.
RNA yield and efficiency of cDNA synthesis, there is a need for
suitable reference genes serving as internal controls to reduce
possible errors between different samples and runs, hence allowing
accurate interpretation of qPCR data29. Common reference genes to
normalize mRNA expression levels are protein-coding genes
(frequently termed housekeeping genes, HKGs), which are consti-
tutively expressed in a wide variety of tissues/cell types with minimal
deviation between different tissue samples and/or under different
experimental conditions30–33. In a previous study on the analysis of
non-protein coding RNA abundance, we proposed the use of ubiqui-
tously expressed housekeeping npcRNAs (HKRs) as reference genes.
Since the biogenesis of most npcRNAs differs from that of protein-
coding mRNAs, the use of HKGs might thus lead to the misinter-
pretation of qPCR data34. In addition to being ubiquitously and
constitutively expressed, the selected reference genes should be
present in similar abundance to the RNA target under investigation.
To determine a set of constitutively expressed npcRNAs with a
wide dynamic range of expression (reference control), RT-qPCR
expression data of eleven selected housekeeping npcRNAs (HKRs)
were analyzed in twenty human tissue samples. HKRs are defined as
npcRNAs exhibiting ubiquitous expression patterns with low tissue
to tissue variation34. The HKRs belong to different structural and
functional classes, are located on different chromosomes to avoid
co-regulatory effects in their expression patterns and were named
according to the snoRNAdatabase35 or as defined by theHUGOgene
nomenclature committee (HGNC; Supplementary Table S1).
For each HKR, the mean quantification cycle (Cq) value, which
represents the number of PCR cycles required to obtain a fluor-
escence signal above a defined threshold level36, was calculated in
Figure 1 | Organization of the human PWS locus. Schematic representation of human 15q11-q13 region (drawing is not to scale). Protein coding and
snoRNA genes are marked as boxes and ovals, respectively. Paternally and maternally expressed genes are shown with dark or white colors,
respectively. Dark bars indicate alternatively spliced exons of the paternally expressed U-UBE3-ATS transcript. Known and suggested U-UBE3-AS
transcripts are shown as black and dashed arrows, respectively. Question marks depict regions with identified internal TSS-tags (see also Supplementary
Figure S7). The PWS imprinting center (PWS-IC) is schematically indicated by a circle.
www.nature.com/scientificreports
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20 human tissues. In general, a Cq difference of 3 in qPCR analysis
indicates a 10-fold change in expression level. The mean Cq values
were calculated for the test set of snoRNAs alongside a set of HKRs
using cDNAs prepared using oligo (dT) 10-12 plus random hexamers.
HKRs were grouped into arbitrary categories as reflected by their
mean Cq values. The first category comprised: 5.8S rRNA, 7SL
scRNA, U1 snRNA and U4 snRNA exhibiting Cq values below 16.
For further analysis, 7SL scRNA was included due to its lower tissue-
to-tissue expression variation. U2 snRNA, U6 snRNA, 7SK RNA and
SCARNA5 (U87 scaRNA) with mean Cq values between 16–25 were
grouped into the second category, whereas U12 snRNA, U5 snRNA
and SNORD105 (U105 snoRNA) with Cq values above 26 were
grouped into the third category (Figure 2A). Notably, RNA structure
and/or post-transcriptional modifications could influence reverse
transcription (RT) efficiency during cDNA synthesizes and thus
significantly affect qPCR-determined true RNA abundance mea-
surements37. We selected at least one HKR from each category
(7SL RNA, U6 snRNA and/or SCARNA5, and U5 snRNA) and set
up an npcRNA expression ruler that could be applied in the data
analysis of novel transcripts.
Comparative expression analysis of snoRNA genes from PWS
locus. snoRNA genes from the PWS-locus were identified more
than a decade ago. However, a detailed analysis of their expression
in different human tissues has not been reported4,14. In order to gain
further insight into the non-protein coding RNA expression within
the PWS-locus, we initially set out to investigate snoRNA genes
located in this region (Figure 1). For these analyses, the npcRNA
expression ruler concept (see above) was applied. Earlier reports
have shown that PWS locus derived snoRNAs are highly expressed
in the brain and some of them could be found in a few other human
tissues4,11. However, as quantitative data concerning their expression
in various tissues were missing, we investigated snoRNAs expression
in 20 different human tissues using RT-qPCR (Figure 2B). All primer
pairs were designed and evaluated according to a standardized
protocol described previously34. In short, primer specificity was
assessed by end-point PCR using human brain cDNA as a
template and only single amplicons were detected (data not
shown). Amplification efficiencies were determined in a qPCR
assay using a 10-fold dilution series of human brain cDNA.
Overall, PWS locus snoRNAs exhibit a difference in expression
range of more than four orders of magnitude and demonstrate the
need of a set of HKRs for accurate data analysis (Figure 2B). In
general, SNORD116 expression levels correlate with the expression
of U6 snRNA and in some tissues with SCARNA5, indicating its high
to medium abundance in the 20 human tissues tested. The
SNORD115 snoRNA gene cluster showed a primarily low expression
level similar to the U5 snRNA expression in the ruler, except in the
Figure 2 | Assembly of the npcRNA ‘expression ruler’ and its application for analysis of snoRNAs fromPWS locus. (A) RT-qPCRmeanCq values for 11
npcRNA HKRs in 20 human tissue cDNA samples. The median Cq values are shown as lines, 25 to 75 Cq percentile as boxes and the range of Cq
values from 20 cDNA samples as whiskers. (B) The ‘‘Expression Ruler’’ applied to investigate snoRNAs from PWS-locus. (C) RT-qPCR analysis of the
human PWS locus snoRNAs. Normalized expression data showing fold change values obtained in 20 different human tissues by qPCR.
www.nature.com/scientificreports
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brain. Expression of SNORD115 in the brain correlates with U6
snRNA indicating its high expression. Hence, consistent with previous
reports, our RT-qPCR data showed that the snoRNAs are differenti-
ally expressed, exhibiting their highest levels in human brain. Notably,
consistent results were obtained for 3 different panels of total RNA
samples using random or gene specific priming during cDNA syn-
thesis (Supplementary Figure S1A-E). Upon further comparison of the
expression patterns of SNORD116, SNORD64, SNORD107 and
SNORD108 snoRNA, highly similar profiles among investigated
human tissues were observed (Figure 2C). These snoRNA genes are
located upstream of the SNORD116 gene cluster and were suggested to
co-transcribe with the proximal part of the host - U-UBE3A-ATS long
npcRNA (Figure 1)3. Hence, in line with previous observations our
data indicate the possibility of co-regulatory expression or processing
of aforementioned snoRNA genes (Figure 2C). When expression pro-
files of the SNORD115 gene cluster were compared with other
snoRNA genes from the PWS locus, their expression patterns deviated
substantially (Figure 2C and 3A). The SNORD109 represents a special
case, as there are two copies of the gene located at different positions
within the PWS locus (Figure 1). The SNORD109A gene is located
proximal to the SNORD116 cluster, whereas SNORD109B is distal to
the SNORD115 gene cluster. Since their sequence is identical, it is not
possible to distinguish between their expression profiles. The detected
combined expression profile of SNORD109A and SNORD109B genes
does not correlate to SNORD116 and SNORD115 genes, additionally
arguing for differential expression of npcRNA in investigated tissues
(Supplementary Figure S2).
To further support the RT-qPCR data, we performed northern
hybridizations for SNORD116 and SNORD115 snoRNAs, as well
as SCARNA5 using specific deoxy-oligonucleotide probes.
Expression patterns shown by northern blot analysis correlated well
with that of RT-qPCR data (Figure 3A and 3B, Supplementary Figure
S3). Notably, in agreement with a recent analysis, we did not detect
psnoRNAs (processed snoRNAs) transcripts (Supplementary Figure
S3)38. However, a longer RNAof approximately 110 nts in lengthwas
detected by northern blot hybridization in a human brain RNA with
a SNORD115 specific probe (Supplementary Figure S3). This RNA
could potentially represent a longer SNORD115 isoform, analogous
to the previously reported L-Snord115 in rat brain39.
The normalized RT-qPCR data is represented as fold change and
is interdependent from the geometric mean of the four reference
RNAs (7SL scRNA, U6 snRNA, SCARNA5 and U5 snRNA). In
our analysis, the normalized HKRs showed variance of around 2-
fold change in expression levels between the individual tissues
underlining their eligibility as reference genes in RT-qPCR.
SNORD116 showed a fold change level above 10 with the highest
expression in brain, ovary and thyroid tissue. The lowest expression
was observed in liver and placenta, in both RT-qPCR and northern
blot analyses (Figure 3A and 3B). In contrast, SNORD115 showed a
more than 1000-fold change in expression levels between individual
tissues indicating a highly variable expression pattern (Figure 3A and
3B). The highest expression was observed in brain, whereas mod-
erate expression was seen in kidney, liver, skeletal muscle and thyr-
oid. The expression in the remaining tissues was low and according
to our analysis, the lowest expression was observed in the spleen
(Figure 3B). Interestingly, Castle et al. 2010, reported the expression
of SNORD116 and SNORD115 in 11 different human tissues14. In
correlation with our results, the authors showed that SNORD116
was present in all tested tissues while SNORD115 was predominantly
expressed in brain with lower levels in kidney, skeletal muscle, liver
and testis. However, SNORD115 expression in other tissues was
barely detected by Castle et al. 201014.
Our next goal was to analyze tissues with the most prominent
deviations in expression patterns between the SNORD116 and
Figure 3 | Comparative expression analysis of SNORD115 and SNORD116. Expression analysis of SNORD115 and SNORD116 among 20 different
human tissues performed by: (A) RT-qPCR and (B) northern blot hybridization. (A) RT-qPCRdata is represented as fold change after normalizationwith
the geometric mean of ‘‘Expression Ruler’’. (B) SCARNA5 serve as loading controls in northern blot hybridization experiments.
www.nature.com/scientificreports
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SNORD115 gene clusters. When snoRNAs expression patterns were
compared across 20 different human tissues, striking differences
were observed in cervix, colon, kidney, liver, lung, prostate, skeletal
muscle, small intestine and spleen (Figure 3A and 3B).
Expression analysis of U-UBE3A-ATS and UBE3A genes. We
performed a further assessment of the expression profile of U-
UBE3A-ATS long non-protein coding RNA across 20 different
human tissues. Human U-UBE3A-ATS RNA transcription is
initiated from paternal unmethylated chromosomal region(s) (U-
exons), located proximally from the PWS-IC center. This long
npcRNA is composed of multiple alternatively spliced exons
including repetitive subtypes of IPW116 and IPW115 exons flanking
SNORD116 and SNORD115 RNA copies, respectively (Figure 1).
Based on exonic sequences and genomic location, U-UBE3A-ATS
transcript could be divided into two parts. The first is the proximal
region, which harbors intronic SNORD64, SNORD107, SNORD108,
SNORD109A genes and SNORD116 cluster. It is composed of
different exons including U-exons and repetitive IPW116 subtypes
(Figure 1). The second region is UBE3A-ATS transcript, which
harbors intronic SNORD109B and the SNORD115 cluster, and
extends distally to overlap the UBE3A gene in cis-antisense
orientation (Figure 1). There are reports suggesting that the
expression of UBE3A-ATS is restricted to the brain, whereas the
proximal transcript could be identified in other tissues (for review40).
To evaluate the expression of different U-UBE3A-ATS regions, we
have designed primers targeting the IPW116, IPW115 and UBE3A
cis-antisense exons (Supplementary Figure S4). Overall, different
exons of U-UBE3A-ATS transcript(s) exhibit a difference in
expression range of more than five orders of magnitude and
demonstrate the need of a set of HKRs for accurate data analysis
(Supplementary Figure S5). When the expression profile of IPW116
exons was investigated, we detected patterns nearly identical to the
SNORD64, SNORD107, SNORD108 and SNORD116 gene clusters
across 20 human tissues (Figure 4A). This observation strongly
supports the notion that investigated RNAs are derived from the
same differentially regulated precursor transcript.
To gain insight into the regulation of the distal end of theU-UBE3-
ATS RNA, we first determined the expression profile of IPW115
exons in different human tissues. We detected the presence of
IPW115 exons in all investigated tissues, arguing for its ubiquitous
nature in humans (Figure 4B). When expression profiles of IPW115
exons and snoRNAs were compared, a closer pattern was observed
with SNORD115, indicating that these RNAs are potentially derived
from the same precursor transcript (Figure 4B). The observed tissue-
specific variations between expression profiles of proximal IPW116
and distal IPW115 exons are in line with differences detected among
PWS – snoRNA genes. Hence, our results suggest additional layers of
expression regulation, namely transcription initiation within the
PWS RNA coding region.
Next, we set out to evaluate tissue-specific expression of the
UBE3A cis-antisense exons from UBE3A-ATS long npcRNA. We
designed primer combinations for two assays: IPW-AS-1 and
IPW-AS-2 targeting different splice exons of UBE3A-ATS RNA.
The AS-2 forward primer was located on the SNORD109B 39-flank-
ing exon, whereas the reverse primer targeted the UBE3A-ATS
region partly antisense to the protein-coding exon of UBE3A
mRNA (Supplementary Figure S4). The IPW-AS-1 assay aimed at
targeting UBE3A-ATS exons that are cis-antisense to the 59-region of
UBE3A gene. Surprisingly, in addition to human brain tissue, both
assays could detect UBE3A cis-antisense long non-protein coding
transcripts within all analyzed tissues. The expression level of long
npcRNA(s) detected by IPW-AS1 and IPW-AS2 assays was compar-
able, and in some tissues even higher than in IPW115 exons
(Figure 5A). However, the IPW115 containing transcript was highly
unregulated in human brain. Unexpectedly, we did not detect
pronounced differences in the abundance of UBE3A cis-antisense
exons in this tissue (Figure 5B). Overall, the expression profiles of
cis-antisense exons did not correlate with IPW116 or IPW115 tran-
scripts, indicating the possibility of independent regulation.
The UBE3A gene is biallelically expressed in most human tissues,
but is imprinted and exclusively expressed from the maternally inher-
ited chromosome in brain. Its specific expression appears to be con-
trolled, at least in part, by the AS imprinting center (AS-IC) that is
located at approximately 35–40 kb upstream of PWS-IC41,42. There
are reports suggesting that epigenetic silencing of UBE3A in human
neurons is controlled and regulated by the expression of UBE3A-ATS
non-protein coding RNA from paternal chromosome40.
When the expression profile of the UBE3A gene was investigated,
we detected a minimal, mostly negligible deviation across 20 human
tissues. Its expression variation was lower than that of 7SL RNA and
U6 snRNA, which are among the most abundant and commonly
used reference RNAs. Based on abundance and low tissue-to-tissue
variation, we suggest the use of the UBE3A transcript as an internal
reference control for future expression analysis (Supplementary
Figure S6). The UBE3A expression profile showed neither positive
nor negative co-regulation with cis-antisense or IPW-exons
(Figure 5B). Hence, our obtained expression data indicate a more
complex regulatory network in the PWS/AS locus and raise a reas-
onable concern for the proposed neuronal-specific function of the
UBE3A cis-antisense transcript(s) in human.
Analysis of CAGE tags. The expression profiles of the investigated
PWS locus derived non-protein coding RNAs prompted us to
examine the possible presence of additional regulatory elements
and transcription start sites within the distal regions of the U-
UBE3A-ATS spanning region. For our analysis we studied RNA-
seq data derived from the 59-Cap Analysis of Gene Expression
(CAGE) tags from various tissues/cell lines and subcellular
compartments43. A complete collection of CAGE-tags representing
potential transcription start sites (TSS) predicted based on Hidden
MarkovModeling (HMM)was obtained from the ENCODE/RIKEN
dataset freely available on the BLAT human genome browser44. All
CAGE tags from the human chromosome 15q11-q13 region were
restricted to selected coordinates (chr15: 25354000 -25598033) of the
UCSC Genome Browser on the human genome, (Feb. 2009
(GRCh37/hg19) Assembly) and were extracted using UNIX script
and manually inspected. In total, 745 CAGE-tag contigs supported
by the Hidden Markov model were identified (Supplementary Table
S2). About two-thirds of the TSS tags were localized to the region
between the SNORD116 and SNROD115 gene clusters, suggesting
possible independent transcription initiation of the distal region of
the U-UBE3A-ATS transcript (Supplementary Figure S7A). The
majority of the remaining CAGE-tags were mapped distal to the
SNORD115 gene array, but proximal to UBE3A cis-antisense exons
of the long npcRNA (Supplementary Figure S7B). This finding
further suggests an internal initiation of transcription within the
PWS non-protein coding RNA containing locus, and partly
explains the difference in expression between the IPW115 and
UBE3A cis-antisense exons of the U-UBE3A-ATS transcript.
Interestingly, analysis of CAGE data from the PWS-locus revealed
a number of TSS tags that map to the U-UBE3A-ATS transcript in
cis-antisense orientation (Supplementary Table S3). Most of them
were derived from the same regions as sense TSS tags, potentially
indicating the presence of euchromatin in this genomic locus. This
could potentially shed light on the ubiquitous expression of the U-
UBE3A-ATS derived npcRNAs in humans.
Discussion
Expression analysis of RNA molecules from the human transcrip-
tome provides essential information about tissue specificity and
regulation, which is important for further functional studies. We
www.nature.com/scientificreports
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set out to analyze the expression of PWS locus derived non-protein
coding RNAs in various human tissues. We chose quantitative real-
time PCR (qPCR) because of its high sensitivity and very low sample
quantity consumption/requirement45–47. However, qPCR needs care-
ful assay design and reaction optimization to maximize sensitivity
and accuracy48,49. The selection of suitable internal controls for data
normalization is pivotal to reduce errors caused by experimental
variations such as starting material, RNA extraction, cDNA prepara-
tions, etc.31. In addition, the differences between expression levels of
the reference gene and the gene of interest could also lead to mis-
Figure 4 | Expression analysis of IPW116 and IPW115 exons. Normalized expression data of IPW116 and IPW115 exons showing fold change values
obtained in 20 different human tissues by qPCR. Expression results indicate that IPW116 exons exhibit an expression pattern similar to SNORD116 (A),
whereas IPW115 exons show similarity to SNORD115 expression across analyzed tissues (B).
www.nature.com/scientificreports
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interpretation. Here, we proposed a set of npcRNAs with vastly
different expression levels as an ‘Expression Ruler’ (Figure 2A). We
recommend using a multiple reference gene concept to cover a wide
expression range for analysis of novel or yet poorly characterized
transcripts.
We applied the Expression Ruler concept, to analyze the expression
levels of small and long non-protein coding RNAs from the PWS locus
in 20 different human tissues. We clearly revealed related profiles from
SNORD64, SNORD107, SNORD108 and SNORD116 snoRNA
(Figure 2C), implying that these RNAs are derived from the same
transcript. A notable difference in expression was observed between
the aforementioned snoRNAs and SNORD115 RNA, suggesting
involvement of additional regulatory elements in regulation of the
distal region of the U-UBE3A-ATS transcript around the SNORD115
gene clusters (Figure 2C). To further support this notion, we investi-
gated the expression of IPW116 and IPW115 exons of U-UBE3A-ATS
transcript(s). The observed differences in expression profiles of exons
of the host gene were similar to the intronic snoRNAs. In contrast,
when the expression profiles of UBE3A cis-antisense exons were ana-
lyzed, we observed neither a correlation with snoRNAs nor with IPW
exons. These results argue for an independent transcription regulation
of UBE3A cis-antisense exons in human tissues. In agreement with
our expression data, detailed analysis of TSS-tags could identify inde-
pendent transcriptional start sites within the U-UBE3A-ATS spanning
region. Collectively, in addition to well-known U-exons, our data
suggest the presence of at least two different regions containing tran-
scription start sites. The first is located between the SNORD116 and
SNORD115 gene clusters, and the second is upstream from the
UBE3A cis-antisense region. Our findings indicate new facets in the
regulation of expression of non-protein coding RNAs in the PWS/AS
locus and open an opportunity for a better understanding of molecular
mechanisms associated with human disorders.
Methods
RNA samples and first-strand cDNA synthesis.Total RNA samples were purchased
from FirstChoiceH Human Total RNA Survey Panel (Ambion); these included
Figure 5 | Comparative expression analysis of UBE3A cis-antisense exons and the UBE3A mRNA. (A) Expression profiles of IPW and UBE3A cis-
antisense exons in different tissues. (B) Comparative analysis of UBE3A and UBE3A cis-antisense transcripts in 20 different human tissues.
www.nature.com/scientificreports
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adipose, bladder, brain, cervix, colon, esophagus, heart, kidney, liver, lung, ovary,
placenta, prostate, skeletal muscle, small intestine, spleen, testes, thymus, thyroid and
trachea tissues. For each tissue, total RNA samples were isolated from respective
tissues collected from three different individuals (Supplementary Table S4).
Total RNA samples were DNase treated, certified for purity and integrity as tested
on the Agilent Bioanalyzer. Total RNA concentration and purity were verified using a
NanoDrop spectrophotometer ND-1000 (Thermo Scientific) by measuring absor-
bance at OD260/280. Furthermore, the presence of DNA contamination was assessed
by PCR as described earlier34.
First strand cDNA synthesis was performed by one of two methods: 1.
SuperScriptH II reverse transcriptase using oligo(dT) and random hexamer primers
(Invitrogen), or 2. reverse transcription using transcriptor reverse transcriptase
(Roche) and pool of gene specific primers.
1. In brief, 5 mg of total RNA was incubated with 0.5 ml of oligo(dT)12-18
(500 mg/ml), 1 ml of random hexamer primers (3 mg/ml) 1 ml of dNTP mix (25 mM
mix) and 7.5 ml of DEPC-treatedwater (Ambion) for 5 min at 65uC. The reaction was
cooled on ice for 2–3 min and briefly centrifugated. Then, 5 ml of first strand syn-
thesis buffer (5 X, containing 250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM
MgCl2), 2 ml of 0.1 M DTT, 2.5 ml of ribolock RNAase inhibitor (40 U/ml,
Fermentas) and 1 ml of (200 U/ml) of SuperScriptH II RTase were added and incu-
bated for 90 min at 42uC. Reverse transcription reaction was terminated by heat
inactivation for 15 min at 75uC and stored at220uC. Final cDNA was diluted 1520
before use in RT-qPCR.
2. Total RNA (0.5 mg) was incubated with 2 ml of 1 mM reverse primer, 1 ml of
dNTP mix (25 mM mix) and 9.5 ml of DEPC-treated water for 10 min at 65uC. The
reaction was cooled on ice for 2–3 min and briefly centrifuged. Then, 4 ml of first
strand synthesis buffer (5 X, containing 250 mM Tris-HCl (pH 8.5), 150 mM KCl,
40 mMMgCl2), 0.5 ml of ribolock RNAase inhibitor (40 U/ml, Fermentas) and 0.5 ml
of (20 U/ml) of Transcriptor reverse transcriptase were added and incubated for
60 min at 55uC. Reverse transcription reaction was terminated by heat inactivation
for 10 min at 85uC. Reaction volumewas increased to 50 ml using nuclease-free water
stored at 220uC. cDNA was diluted 1510 prior to use in a real-time PCR reaction.
Reverse-transcription quantitative real-time PCR. All details on the primers used
for RT-qPCR analysis in this study are given in Supplementary Table S1. Primer pairs
were taken from a previous study or designed and analyzed accordingly34. All cDNAs
prepared with method 1 were used in the RT-qPCR reactions that were performed in
triplicate along with non-template-controls in 384-well microtitre plates on an ABI
Prism 7900 HT sequence detector system (Applied Biosystems). Amplification was
performed in a final reaction volume of 10 ml, starting with a 2 min activation step at
50uC, 10 min template denaturation step at 95uC, followed by 40 cycles of 15 sec at
95uC and 1 min at 60uC. SYBRGreen assay also included amelt curve analysis step at
the end of the cycling protocol, with continuous fluorescence measurement from 60–
95uC. All reactions contained 2 ml of cDNA (20 ng), 5 ml of 2 X SYBR Green Master
Mix (Applied Biosystems) and 1 ml containing 10 mM of each primer and 2 ml of
DEPC treated water (Ambion). Cq values were determined for all runs applying SDS
software v. 2.1 (Applied Biosystems) using automatic baseline settings and a
threshold value of 0.2. Results were exported to GraphPad Prism for further analysis.
cDNA samples prepared using protocol 2 were used in real-time PCR assays using
the Roche Light Cycler 480 SYBR Green master mix. In a 10 ml reaction, 2 ml of
diluted cDNAwas added to 5 ml of 2X SYBR greenmastermix (Roche), 2 ml nuclease-
free water and 1 ml of 10 mM primer mix. Real-time PCR amplification reaction
included 5 minutes of activation/initial denaturation step followed by 40 cycles of
20 sec at 95uC, 40 sec at 60uC and 1 min extension at 72uC. The reaction included
single acquisition of fluorescent signal at 60uC for each cycle and continuous
acquisition from 50uC to 97uC at the end of the 40 cycles for melt-curve analysis. All
the data produced using automatic baseline settings and a threshold value of 0.2 were
transferred to Excel files for subsequent analysis.
Data analysis was carried out using a geometric mean of at least 3 selected
housekeeping RNAs used in the study and the fold change is represented as 2DCq
(Supplementary Table S5) Results were exported to a GraphPad Prism for further
analysis. The Minimum Information for Publication of Quantitative Real-Time PCR
Experiments (MIQE) guidelines was followed50. The MIQE checklist is presented as
Supplementary Table S6.
Northern blot analysis. Three mg of each total RNA were separated on 8% (w/v)
denaturing polyacrylamide gel (PAAG; 7 M urea, 1 X TBE buffer) at 200 V for
90 min. Total RNA samples from PAAG were transferred onto positively charged
nylon membranes (BrightStar Plus, Ambion or Hybond-N1, Amersham
Biosciences) using a Trans-blot semi-dry blotting apparatus (BioRad) at 400 mA for
45 min in 0.5 X TBE buffer (90 mM Tris, 64.6 mM boric acid, 2.5 mM EDTA, pH
8.3). After immobilizing RNA using a cross linker (STRATAGENE) at 1200 J/cm2,
nylon membranes were pre-hybridized for 1–3 hrs in Ultrahyb Oligo hybridization
buffer (Ambion) at 42uC.
To determine npcRNA candidates, hybridizations were performed with RT-qPCR
reverse primers or reverse complement oligos to the RT-qPCR forward primers.
Hybridization probes were prepared by end labeling with c-[32P]-ATP using T4
polynucleotide kinase (Fermentas). Hybridization was carried out at 42uC in
Ultrahyb Oligo hybridization buffer for 12–16 hrs. Blots were washed twice at room
temperature in 2 X SSC buffer (20 mM sodium phosphate, 0.3 M NaCl, 2 mM
EDTA, pH 7.4) containing 0.5% SDS for 2 X 30 min (washing repeated if the blot
showed high counts). Membranes were exposed to MS-film (Kodak) and developed
after 1–2 hrs or, if necessary, further exposed for longer time periods at 280uC.
Analysis of CAGE reads for promoter marks. CAGE clusters were accessed via the
UCSC server (www.genome.ucsc.edu/cgi-bin/hgBlat?command5start), combined
and intersected with the PWS regions. Simple gawk scripts collect all transcriptional
start site (TSS) annotated clusters that localize to the human chromosome 15 between
25354000 and 25598033 resides (Feb. 2009 (GRCh37/hg19) Assembly), respectively.
Clusters that are expressed on the sense strand are considered to be a TSS - candidate.
Gawk scripts again compute the separation in antisense and sense transcripts.
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